湖北宜化(000422.SZ):控股股東擬增持0.5億元-1億元的公司股份
格隆匯5月25日丨湖北宜化(000422.SZ)公佈,公司於2023年5月25日收到控股股東湖北宜化集團有限責任公司(簡稱“宜化集團”)《關於增持湖北宜化化工股份有限公司股份的吿知函》,宜化集團計劃自2023年5月29日起的6個月內,通過深圳證券交易所交易系統(包括但不限於集中競價、大宗交易等),以自有資金擇機增持公司股份,本次擬增持股份金額不低於5000萬元,不超過1億元。本次增持不設置價格區間,宜化集團將根據公司股票價格波動情況及資本市場整體趨勢,逐步實施增持計劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.